SLCTR/2015/026已完成2 期
Therapeutic evaluation of the antipyretic activity of the Ayurvedic preparation Sudarshana Suspension in febrile children.
HETC Project, Ministry of Higher Education0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
Following treatment with the novel preparation Sudarshana suspension, fever completely resolved within 72 hours. However, when palatability of the two preparations was concerned it was found that the palatability of the Sudarshana suspension was much better and the compliance was higher (Figures 4.15). The overall efficacy of the new drug; Sudarshana suspension (SS) was significant (p< 0.005) in comparison to the standardized Ayurveda drug, Sudarshana powder (SP).
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Children of either sex aged 6- 12 years at the time of enrollment
- •2. Axillary temperature of 37. 5°C or above at arrival and/or after one hours observation
- •3. No other antipyretic medication given
- •4. Admitted by parents or legal guardians who can write and read English or Sinhala
- •5. Only patients with fever with no other signs and symptoms of systemic illness
排除标准
- •1. Weight below the third centile for age
- •2. Those receiving anticoagulant treatment
- •3. History of intolerance to Sudarshana powder or similar compounds
- •4. Previous occurrence or current symptoms of peptic ulceration or gastrointestinal bleeding
- •5. Diagnosis of severe liver, heart, kidney, or systemic disease including malignancy
- •6. On other medication which needs to be taken during the study or in the six hours prior to recruitment
- •7. Those receiving any other antipyretic or anti inflammatory drugs.
- •8. Any history of drug allergy.
研究者
相似试验
招募中
2 期
Antisecretory Factor In Severe Traumatic Brain InjuryTraumatic Brain InjuryNCT04117672Peter Siesjö20
尚未招募
不适用
Evaluation of a herbal antiseptic for wound infectionsCTRI/2020/11/028874Dr Vikas Gautam
尚未招募
不适用
Testing of a herbal antiseptic for wound infectionsCTRI/2020/11/029257Dr Vikas Gautam
尚未招募
4 期
Immunity enhancing in Rheumatoid ArthritisCTRI/2020/08/027370All India Institure of Ayurveda
已完成
1 期
Treatment of sialorrhea by combined use of muscarinic M1 and M3 receptor selective antagonistssialorrheaJPRN-UMIN000031765Tokyo Women's medical university6